A citation-based method for searching scientific literature

Yunjuan Zhao, Lin Yang, Yufei Xiang, Lingjiao Liu, Gan Huang, Zhaofeng Long, Xia Li, R David Leslie, Xiangbing Wang, Zhiguang Zhou. J Clin Endocrinol Metab 2014
Times Cited: 69







List of co-cited articles
640 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


C-peptide levels in latent autoimmune diabetes in adults treated with linagliptin versus glimepiride: exploratory results from a 2-year double-blind, randomized, controlled study.
Odd Erik Johansen, Bernhard O Boehm, Valdemar Grill, Peter A Torjesen, Sudipta Bhattacharya, Sanjay Patel, Kristiane Wetzel, Hans-Juergen Woerle. Diabetes Care 2014
39
79

Saxagliptin improves glycaemic control and C-peptide secretion in latent autoimmune diabetes in adults (LADA).
R Buzzetti, P Pozzilli, R Frederich, N Iqbal, B Hirshberg. Diabetes Metab Res Rev 2016
29
86

Effect of sitagliptin on glucose control in adult patients with Type 1 diabetes: a pilot, double-blind, randomized, crossover trial.
S L Ellis, E G Moser, J K Snell-Bergeon, A S Rodionova, R M Hazenfield, S K Garg. Diabet Med 2011
88
33

Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7.
Mohammed I Hawa, Hubert Kolb, Nanette Schloot, Huriya Beyan, Stavroula A Paschou, Raffaella Buzzetti, Didac Mauricio, Alberto De Leiva, Knud Yderstraede, Henning Beck-Neilsen,[...]. Diabetes Care 2013
158
33

Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in China (LADA China study): a nationwide, multicenter, clinic-based cross-sectional study.
Zhiguang Zhou, Yufei Xiang, Linong Ji, Weiping Jia, Guang Ning, Gan Huang, Lin Yang, Jian Lin, Zhenqi Liu, William A Hagopian,[...]. Diabetes 2013
134
33

Reversal of new-onset diabetes through modulating inflammation and stimulating beta-cell replication in nonobese diabetic mice by a dipeptidyl peptidase IV inhibitor.
Lei Tian, Jie Gao, Jianqiang Hao, Yu Zhang, Huimin Yi, Timothy D O'Brien, Robert Sorenson, Jian Luo, Zhiguang Guo. Endocrinology 2010
84
28

Insulin intervention in slowly progressive insulin-dependent (type 1) diabetes mellitus.
Taro Maruyama, Shoichiro Tanaka, Akira Shimada, Osamu Funae, Akira Kasuga, Azuma Kanatsuka, Izumi Takei, Satoru Yamada, Norikazu Harii, Hiroki Shimura,[...]. J Clin Endocrinol Metab 2008
71
27


Addition of exenatide or sitagliptin to insulin in new onset type 1 diabetes: a randomized, open label study.
K V S Hari Kumar, Altamash Shaikh, Pitambar Prusty. Diabetes Res Clin Pract 2013
59
30

Effect of sitagliptin on post-prandial glucagon and GLP-1 levels in patients with type 1 diabetes: investigator-initiated, double-blind, randomized, placebo-controlled trial.
Satish K Garg, Emily G Moser, Bruce W Bode, Leslie J Klaff, William R Hiatt, Christie Beatson, Janet K Snell-Bergeon. Endocr Pract 2013
66
27

Latent autoimmune diabetes in adults (LADA) should be less latent.
S Fourlanos, F Dotta, C J Greenbaum, J P Palmer, O Rolandsson, P G Colman, L C Harrison. Diabetologia 2005
195
24

Interventions for latent autoimmune diabetes (LADA) in adults.
Sinead Brophy, Helen Davies, Sopna Mannan, Huw Brunt, Rhys Williams. Cochrane Database Syst Rev 2011
43
37

High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes.
Raffaella Buzzetti, Sergio Di Pietro, Andrea Giaccari, Antonio Petrone, Mattia Locatelli, Concetta Suraci, Marco Capizzi, Maria Luisa Arpi, Elena Bazzigaluppi, Francesco Dotta,[...]. Diabetes Care 2007
135
23

Possible Long-Term Efficacy of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, for Slowly Progressive Type 1 Diabetes (SPIDDM) in the Stage of Non-Insulin-Dependency: An Open-Label Randomized Controlled Pilot Trial (SPAN-S).
Takuya Awata, Akira Shimada, Taro Maruyama, Yoichi Oikawa, Nobuyuki Yasukawa, Susumu Kurihara, Yumi Miyashita, Masako Hatano, Yuichi Ikegami, Masafumi Matsuda,[...]. Diabetes Ther 2017
23
69

Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.
T Tuomi, A Carlsson, H Li, B Isomaa, A Miettinen, A Nilsson, M Nissén, B O Ehrnström, B Forsén, B Snickars,[...]. Diabetes 1999
354
21

The DPP4 inhibitor linagliptin delays the onset of diabetes and preserves β-cell mass in non-obese diabetic mice.
Jacob Jelsing, Niels Vrang, Søren B van Witteloostuijn, Michael Mark, Thomas Klein. J Endocrinol 2012
35
40


Rosiglitazone preserves islet beta-cell function of adult-onset latent autoimmune diabetes in 3 years follow-up study.
Zhifang Yang, Zhiguang Zhou, Xia Li, Gan Huang, Jian Lin. Diabetes Res Clin Pract 2009
38
34

Dipeptidyl peptidase IV inhibitor treatment stimulates beta-cell survival and islet neogenesis in streptozotocin-induced diabetic rats.
J Andrew Pospisilik, Jennifer Martin, Timothy Doty, Jan A Ehses, Nathalie Pamir, Francis C Lynn, Shalea Piteau, Hans-Ulrich Demuth, Christopher H S McIntosh, Raymond A Pederson. Diabetes 2003
269
17

LADA and CARDS: a prospective study of clinical outcome in established adult-onset autoimmune diabetes.
Mohammed Iqbal Hawa, Ana Paula Buchan, Thomas Ola, Chuan Chuan Wun, David A DeMicco, Weihang Bao, D John Betteridge, Paul N Durrington, John H Fuller, H Andrew W Neil,[...]. Diabetes Care 2014
44
27

The many faces of diabetes: a disease with increasing heterogeneity.
Tiinamaija Tuomi, Nicola Santoro, Sonia Caprio, Mengyin Cai, Jianping Weng, Leif Groop. Lancet 2014
282
17

GADA titer-related risk for organ-specific autoimmunity in LADA subjects subdivided according to gender (NIRAD study 6).
Simona Zampetti, Marco Capizzi, Marialuisa Spoletini, Giuseppe Campagna, Gaetano Leto, Laura Cipolloni, Claudio Tiberti, Emanuele Bosi, Alberto Falorni, Raffaella Buzzetti. J Clin Endocrinol Metab 2012
48
25


The new insights from DPP-4 inhibitors: their potential immune modulatory function in autoimmune diabetes.
Yunjuan Zhao, Lin Yang, Xiangbing Wang, Zhiguang Zhou. Diabetes Metab Res Rev 2014
39
30

High GADA titer increases the risk of insulin requirement in LADA patients: a 7-year follow-up (NIRAD study 7).
Simona Zampetti, Giuseppe Campagna, Claudio Tiberti, Marco Songini, Maria Luisa Arpi, Giuseppina De Simone, Efisio Cossu, Lorenzo Cocco, John Osborn, Emanuele Bosi,[...]. Eur J Endocrinol 2014
32
37

Latent Autoimmune Diabetes in Adults in the United Arab Emirates: Clinical Features and Factors Related to Insulin-Requirement.
Ernesto Maddaloni, Nader Lessan, Alia Al Tikriti, Raffaella Buzzetti, Paolo Pozzilli, Maha T Barakat. PLoS One 2015
38
31

Vildagliptin reduces glucagon during hyperglycemia and sustains glucagon counterregulation during hypoglycemia in type 1 diabetes.
Johan Farngren, Margaretha Persson, Anja Schweizer, James E Foley, Bo Ahrén. J Clin Endocrinol Metab 2012
63
17


Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in North America and Europe.
Bernard Zinman, Steven E Kahn, Steven M Haffner, M Colleen O'Neill, Mark A Heise, Martin I Freed. Diabetes 2004
109
15

Genetic similarities between latent autoimmune diabetes in adults, type 1 diabetes, and type 2 diabetes.
Camilla Cervin, Valeriya Lyssenko, Ekaterine Bakhtadze, Eero Lindholm, Peter Nilsson, Tiinamaija Tuomi, Corrado M Cilio, Leif Groop. Diabetes 2008
135
15


Adult-onset autoimmune diabetes: current knowledge and implications for management.
Raffaella Buzzetti, Simona Zampetti, Ernesto Maddaloni. Nat Rev Endocrinol 2017
77
15


Latent autoimmune diabetes in adults with low-titer GAD antibodies: similar disease progression with type 2 diabetes: a nationwide, multicenter prospective study (LADA China Study 3).
Lingjiao Liu, Xia Li, Yufei Xiang, Gan Huang, Jian Lin, Lin Yang, Yunjuan Zhao, Zhifang Yang, Can Hou, Yijun Li,[...]. Diabetes Care 2015
49
20

Number of autoantibodies and HLA genotype, more than high titers of glutamic acid decarboxylase autoantibodies, predict insulin dependence in latent autoimmune diabetes of adults.
M Maioli, G M Pes, G Delitala, L Puddu, A Falorni, F Tolu, R Lampis, V Orrù, G Secchi, A M Cicalò,[...]. Eur J Endocrinol 2010
44
22



Rosiglitazone combined with insulin preserves islet beta cell function in adult-onset latent autoimmune diabetes (LADA).
Zhiguang Zhou, Xia Li, Gan Huang, Jian Peng, Lin Yang, Xiang Yan, Jianping Wang. Diabetes Metab Res Rev 2005
43
23

Sitagliptin inhibit human lymphocytes proliferation and Th1/Th17 differentiation in vitro.
Marcelo Maia Pinheiro, Caroline Lais Stoppa, Claudete Justina Valduga, Cristina Eunice Okuyama, Renata Gorjão, Regina Mara Silva Pereira, Susana Nogueira Diniz. Eur J Pharm Sci 2017
38
26

Dulaglutide treatment results in effective glycaemic control in latent autoimmune diabetes in adults (LADA): A post-hoc analysis of the AWARD-2, -4 and -5 Trials.
Paolo Pozzilli, Richard D Leslie, Anne L Peters, Raffaella Buzzetti, Sudha S Shankar, Zvonko Milicevic, Imre Pavo, Jeremie Lebrec, Sherry Martin, Nanette C Schloot. Diabetes Obes Metab 2018
17
58

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.
Benjamin M Scirica, Deepak L Bhatt, Eugene Braunwald, P Gabriel Steg, Jaime Davidson, Boaz Hirshberg, Peter Ohman, Robert Frederich, Stephen D Wiviott, Elaine B Hoffman,[...]. N Engl J Med 2013
13

Higher serum DPP-4 enzyme activity and decreased lymphocyte CD26 expression in type 1 diabetes.
Tímea Varga, Anikó Somogyi, Gábor Barna, Barna Wichmann, Géza Nagy, Károly Rácz, László Selmeci, Gábor Firneisz. Pathol Oncol Res 2011
39
23

Sitagliptin exerts an antinflammatory action.
Antoine Makdissi, Husam Ghanim, Mehul Vora, Kelly Green, Sanaa Abuaysheh, Ajay Chaudhuri, Sandeep Dhindsa, Paresh Dandona. J Clin Endocrinol Metab 2012
170
13

Metabolic syndrome and autoimmune diabetes: action LADA 3.
Mohammed I Hawa, Charles Thivolet, Didac Mauricio, Irene Alemanno, Elisa Cipponeri, David Collier, Steven Hunter, Raffaella Buzzetti, Alberto de Leiva, Paolo Pozzilli,[...]. Diabetes Care 2009
73
13

Clinical, autoimmune, and genetic characteristics of adult-onset diabetic patients with GAD autoantibodies in Japan (Ehime Study).
Haruyo Takeda, Eiji Kawasaki, Ikki Shimizu, Etsushi Konoue, Masao Fujiyama, Satoshi Murao, Kiyonobu Tanaka, Kennichi Mori, Yoshinao Tarumi, Isamu Seto,[...]. Diabetes Care 2002
79
13

Genetic analysis of adult-onset autoimmune diabetes.
Joanna M M Howson, Silke Rosinger, Deborah J Smyth, Bernhard O Boehm, John A Todd. Diabetes 2011
78
13

Markers of β-Cell Failure Predict Poor Glycemic Response to GLP-1 Receptor Agonist Therapy in Type 2 Diabetes.
Angus G Jones, Timothy J McDonald, Beverley M Shields, Anita V Hill, Christopher J Hyde, Bridget A Knight, Andrew T Hattersley. Diabetes Care 2016
70
13

One year remission of type 1 diabetes mellitus in a patient treated with sitagliptin.
Marcos M Lima-Martínez, Ernesto Guerra-Alcalá, Miguel Contreras, José Nastasi, Janelle A Noble, Constantin Polychronakos. Endocrinol Diabetes Metab Case Rep 2014
12
75

Four-year clinical remission of type 1 diabetes mellitus in two patients treated with sitagliptin and vitamin D3.
Marcelo Maia Pinheiro, Felipe Moura Maia Pinheiro, Margareth Afonso Torres. Endocrinol Diabetes Metab Case Rep 2016
14
64

The efficacy and safety of DPP4 inhibitors in patients with type 1 diabetes: A systematic review and meta-analysis.
Heming Guo, Chen Fang, Yun Huang, Yufang Pei, Linqi Chen, Ji Hu. Diabetes Res Clin Pract 2016
32
28


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.